ATHN Stock Recent News Athenahealth (ATHN) 125.03 11/14/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Athenahealth (ATHN) 125.03 $ATHN

Stock Picking Grades For All Cap Growth Style Fund Managers
David Trainer - Seeking Alpha - Wed Nov 12, 8:30AM CST
This report shows how well All Cap Growth mutual fund managers pick stocks. We juxtapose our Portfolio Management Rating on funds, which grades managers based on the quality of the stocks they choose, with the number of good stocks available in the...
INTC: 33.95 (+0.27), ATHN: 125.03 (+0.61)

Comparing America's 3 Largest Healthcare Information Services Companies
Joseph Cafariello - at Seeking Alpha - Mon Nov 10, 9:42AM CST

VEEV: 28.00 (-0.38), CERN: 64.31 (-0.22), ATHN: 125.03 (+0.61)

Allscripts Healthcare: Blue Harbour Group Won't Go Lightly
Marshall Hargrave - at Seeking Alpha - Wed Nov 05, 12:39PM CST

MDRX: 12.44 (-0.02), CERN: 64.31 (-0.22), ATHN: 125.03 (+0.61)

Alere (ALR) Lags Q3 Earnings, Revenues; Outlook Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 12:40PM CDT
Alere Inc. (ALR) reported disappointing third-quarter 2014 results as both the top and the bottom line missed the Zacks Consensus Estimate by a wide margin
BIO: 111.90 (+0.36), ALR: 40.00 (-0.01), CERN: 64.31 (-0.22), ATHN: 125.03 (+0.61)

11.7% Return Seen to Date on SmarTrend athenahealth Call (ATHN)
Comtex SmarTrend(R) - Mon Oct 27, 10:02AM CDT
SmarTrend identified a Downtrend for athenahealth (NASDAQ:ATHN) on September 15th, 2014 at $132.36. In approximately 1 month, athenahealth has returned 11.68% as of today's recent price of $116.90.
ATHN: 125.03 (+0.61)

Cerner Sees In-Line Q3 Earnings but Revenues Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:50AM CDT
For the fourth quarter of 2014, Cerner Corporation (CERN) anticipates revenues between $880 and $915 million
QSII: 14.89 (-0.10), MDRX: 12.44 (-0.02), CERN: 64.31 (-0.22), ATHN: 125.03 (+0.61)

Agreements, Financial Results, Upcoming Conference Calls, Analysis Results, and Technical Updates - Research Reports on SunEdison, Avago, LinkedIn, Equinix and athenahealth
PR Newswire - Wed Oct 22, 7:45AM CDT
Today, Analysts Review released its research reports regarding SunEdison, Inc. (NYSE: SUNE), Avago Technologies Limited (NASDAQ: AVGO), LinkedIn Corporation (NYSE: LNKD), Equinix, Inc. (NASDAQ: EQIX) and athenahealth, Inc. (NASDAQ: ATHN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7364-100free.
EQIX: 222.09 (+0.12), LNKD: 233.89 (+4.12), SUNE: 16.93 (+0.09), AVGO: 89.01 (+1.57), ATHN: 125.03 (+0.61)

Einhorn: Selloff Created Buying Opportunities, Embrace Higher Interest
at The Street - Tue Oct 21, 2:09PM CDT
The trading panels hosts hedge fund manager David Einhorn and looks at what to make of earnings from Coca-Cola, McDonald's and Chipotle.
KO: 42.73 (-0.06), CCI: 80.39 (+0.18), MU: 32.62 (-0.32), VRX: 134.21 (+2.31), WWE: 11.94 (-0.19), SPWR: 27.52 (-0.56), INTC: 33.95 (+0.27), ATHN: 125.03 (+0.61), AGN: 198.65 (+2.44), NFLX: 386.04 (+6.63), FIG: 7.74 (+0.13), SUNE: 16.93 (+0.09), TXN: 51.63 (+0.45), CMG: 669.80 (-0.95), AAL: 44.01 (-0.11), MCD: 96.21 (+0.73), AAPL: 114.18 (+1.36)

athenahealth Q3 Earnings Fall but Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 9:30AM CDT
For the full year 2014, athenahealth (ATHN) reiterated its revenues guidance of $725 to $755 million
ZLTQ: 27.69 (+0.92), GWPH: 75.63 (-0.21), OMCL: 32.26 (-0.30), ATHN: 125.03 (+0.61)

athenahealth Has Returned 14.2% Since SmarTrend Recommendation (ATHN)
Comtex SmarTrend(R) - Mon Oct 20, 9:26AM CDT
SmarTrend identified a Downtrend for athenahealth (NASDAQ:ATHN) on September 15th, 2014 at $132.36. In approximately 1 month, athenahealth has returned 14.25% as of today's recent price of $113.50.
ATHN: 125.03 (+0.61)

athenahealth Set to Possibly Rebound After Yesterday's Selloff of 7.25%
Comtex SmarTrend(R) - Fri Oct 17, 4:32PM CDT
athenahealth (NASDAQ:ATHN) traded in a range yesterday that spanned from a low of $107.88 to a high of $117.56. Yesterday, the shares fell 7.2%, which took the trading range below the 3-day low of $117.75 on volume of 2.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ATHN: 125.03 (+0.61)

GE and Urban Outfitters are big market movers
AP - Fri Oct 17, 3:31PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
URBN: 30.85 (-0.80), GE: 26.46 (+0.04), CLV: 10.30 (+0.42), RPRX: 9.34 (-0.26), CLF: 10.69 (+0.33), ATHN: 125.03 (+0.61), MS: 35.69 (-0.15)

Stocks Up Big Friday, Recover Early Week Losses
at Investor's Business Daily - Fri Oct 17, 3:24PM CDT
Stocks finished with big gains Friday, posting their best day in six sessions. Blue chips led, with the Dow Jones industrial average rising 1.6%, while the S&P 500 climbed 1.3% and the Nasdaq finished 1.0% higher. Preliminary data show volume coming...
VRX: 134.21 (+2.31), GILD: 102.06 (-2.14), AKRX: 38.21 (+0.53), CMG: 669.80 (-0.95), ILMN: 180.50 (-4.50), DIS: 90.80 (+0.31), AAPL: 114.18 (+1.36), ATHN: 125.03 (+0.61)

What's Behind Athenahealth's So-So Earnings
Keith Speights, The Motley Fool - Motley Fool - Fri Oct 17, 1:14PM CDT
Investors looking for a return of high-flying momementum of the past from athenahealth might still be looking. The cloud-based health services company announced third quarter results Thursday that didn't cause much jubilation but weren't too...
ATHN: 125.03 (+0.61)

athenahealth's (ATHN) CEO Jonathan Bush on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 17, 1:06PM CDT

ATHN: 125.03 (+0.61)

ATHENAHEALTH
at Investor's Business Daily - Thu Oct 16, 5:49PM CDT
ATHENAHEALTH (ATHN) said Q3 EPS fell 6.9% to 27 cents, in line with views. Revenue rose 25.7% to $190.43 bil vs. views for $190.4 bil. Shares fell 2% to 118.05.
ATHN: 125.03 (+0.61)

athenahealth, Inc. Reports Third Quarter Fiscal Year 2014 Results
GlobeNewswire - Thu Oct 16, 4:46PM CDT
Company Announces Record Physician Additions
ATHN: 125.03 (+0.61)

Athenahealth reports 3Q loss
Automated Insights - Thu Oct 16, 3:31PM CDT
WATERTOWN, Mass. (AP) _ Athenahealth Inc. (ATHN) on Thursday reported a loss of $1.6 million in its third quarter.
ATHN: 125.03 (+0.61)

athenahealth revenue up 26%
Seeking Alpha - at Seeking Alpha - Thu Oct 16, 3:28PM CDT

ATHN: 125.03 (+0.61)

Athenahealth EPS and revenue in-line
Seeking Alpha - at Seeking Alpha - Thu Oct 16, 3:03PM CDT

ATHN: 125.03 (+0.61)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI-Driven Software Growth Faces Profitability Hurdles

Updated Category News Views 153

AI and Growth: A Tale of Two Strategies Is AI the superhero we’ve been waiting for, or just another fad? The KeyBanc Capital Markets' 2026 AI x Software Benchmark throws more questions into the ring than it answers. This benchmark isn't just numbers on a page; it's a pulse check on how AI is reshaping the software landscape. Seeing AI-native firms grow at a dizzying 34%...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 155

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Dana Concludes Tender Offers for Senior Notes

Updated Category News Views 130

An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...

Continue Reading
Noël Jolié's Cream Earns Spot on Oprah's List

Updated Category News Views 98

The Powerhouse of Oprah's Seal of Approval Ever notice what happens when Oprah drops a nod towards any brand? It's like Midas touching everything gold. That's exactly the scenario with Noël Jolié, a Chicago-based luxury body care operation, hitting the jackpot by landing its Velours Silken Body Cream on Oprah's Favorite Things 2026. You can't buy this kind of press,...

Continue Reading
Euroandinos Paita Closes Consent for 2037 Notes

Updated Category News Views 122

Port Strategy and Financial Implications Terminales Portuarios Euroandinos Paita S.A., nestled in the Peruvian transport sector, has been tight-rope walking through its debt landscape. Announcing a successful consent solicitation on November 13, 2026, they've taken a significant step towards reconfiguring their long-term financing game. This puppet show of paperwork...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 227

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
PangeAI and Sky Blue Transform Data Center Decisions

Updated Category News Views 148

Just when you thought the incessant trials of picking a prime data center site couldn’t get any more grueling or expensive, enter PangeAI and its brand-new ally, Sky Blue Impact. These tech firms have partnered up to speed up what has traditionally been a sluggish, pricey process. Here’s the deal: PangeAI’s geospatial AI platform lets Sky Blue dodge the usually...

Continue Reading
Will Hair Loss Drugs Challenge Transplant Clinics?

Updated Category News Views 73

Emerging Treatments Stir Up Hair Loss Scene You ever get the feeling we're on the brink of something big? That's where we are with hair loss treatments, folks. As of late 2026, new drugs are making waves in clinical trials, but they’re not yet giving hair transplant clinics any sleepless nights. Smile Hair Clinic's co-founders, Dr. Mehmet Erdo?an and Dr. Gökay Bilgin,...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 85

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 126

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming a Small Investment in Royal Caribbean Into Wealth

Updated Category News Views 156

The Power of Long-Term Investing in Royal Caribbean Investing in the stock market can often seem intimidating, especially for newcomers. However, a closer look at companies like Royal Caribbean Gr (NASDAQ: RCL) demonstrates the potential rewards of disciplined investing over time. Having shown remarkable performance, Royal Caribbean has an annualized return that exceeds...

Continue Reading
Immuron's Financial Growth and Clinical Progress Update

Updated Category News Views 149

Immuron's Consistent Growth and Exciting Projects Update Immuron Limited, a biopharmaceutical company based in Australia and publicly traded on the NASDAQ under the ticker IMRN and ASX ticker IMC.AX, is announcing some significant updates that reflect its ongoing commitment to healthcare innovation. The company's recent sales figures and progress in clinical trials...

Continue Reading
General Motors Growth Potential: Insights from Analysts

Updated Category News Views 281

General Motors Gets a Boost from Analysts In recent developments, General Motors Company (NYSE: GM) has garnered notable attention from financial analysts, particularly following Barclays' upgrade of the stock. The analysts play a vital role in assessing the market potential for stocks, and their insights can greatly influence investor confidence. Analyst Upgrades Impact...

Continue Reading
BioAge Labs Faces Class Action Lawsuit: Deadline Approaches Soon

Updated Category News Views 314

BioAge Labs Faces Class Action Lawsuit Investors of BioAge Labs, Inc. (NASDAQ: BIOA) are currently navigating a challenging landscape as a class action lawsuit is underway against the biopharmaceutical company. This underscores the importance for shareholders to stay informed about the developments following the company's recent stock performance and ensuing legal...

Continue Reading
Audit BEE Celebrates Dual Honors at Global Brand Awards

Updated Category News Views 177

Audit BEE Wins Prestigious Global Brand Awards Audit BEE has achieved remarkable recognition for its Excellence in Compliance and Advisory Leadership, recently celebrated at the prestigious Global Brand Awards. These awards, organized by Global Brands Magazine, acknowledge outstanding contributions from brands worldwide, showing the importance of excellence across various...

Continue Reading